Filing Details
Indaptus Therapeutics, Inc. (NASDAQ:INDP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:INDP
Indaptus Therapeutics, Inc. (INDP) Files Quarterly Report for Q0
Indaptus Therapeutics, Inc. (NASDAQ:INDP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
At publication ·
What changed
Indaptus Therapeutics, Inc. (NASDAQ:INDP) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Indaptus Therapeutics (NASDAQ: INDP) filed its quarterly report (Form 10-Q) on August 13, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $1.06 per share with a market capitalization of $4.5 million.
- The article does not disclose Q0 revenue figures, limiting visibility into the company's financial performance for the reported period.
Market Context
Indaptus Therapeutics, Inc.'s stock currently trades at $1.06 with a market capitalization of $4.5M.
The 10-Q provides Indaptus Therapeutics, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Indaptus Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View INDP Stock Page
Frequently Asked Questions
Where can I read INDP's SEC filings?
Browse all filings on our INDP SEC filings page.
What types of SEC filings does Indaptus Therapeutics, Inc. file?
Public companies like Indaptus Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.